AXSM Axsome Therapeutics, Inc.
$134.00
Axsome Therapeutics, Inc. (AXSM) Earnings News
Earnings press releases, previews and reviews for Axsome Therapeutics, Inc. (AXSM), newest first. Our most recent is review: Axsome Beats Handily as Auvelity Growth Accelerates, but a Battered Stock Shows Investors Still Doubt the Ramp.
Monday
November 2, 2026
9:16 AM ET
Axsome Beats Handily as Auvelity Growth Accelerates, but a Battered Stock Shows Investors Still Doubt the Ramp
Earnings Whispers · Review
Monday
November 2, 2026
7:00 AM ET
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Monday
October 26, 2026
11:39 AM ET
Axsome's Alzheimer's Agitation Launch Faces First Full-Quarter Test as Shares Slide Toward Lows
Earnings Whispers · Preview
Wednesday
October 7, 2026
7:00 AM ET
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
Monday
August 10, 2026
7:00 AM ET
Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Tuesday
July 14, 2026
7:00 AM ET
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10